drugset / Trial / NCT01267006

Blood Levels and Effects of GSK1325756 in Healthy Adult Volunteers Aged 40 to 80 Years Old

NCT01267006

Phase 1 Completed 40 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blindBasic science

Summary

This study will invite two groups of volunteers to participate. The data from one group of volunteers will be used to find out how much study drug, known as GSK1325756, is in the blood after taking the drug twice in one day. Data will also collected to find out if the level of cetain blood cells, known as neutrophils, change significantly after taking the study drug twice in one day. This group of volunteers will be aged 40 to 64 years of age. The data from the other group of volunteers will be used to find out if taking the study drug, GSK1325756, twice in one day with or without food, makes a difference to the level of study drug in the blood. This group of volunteers will also provide data to find out if any study drug metabolites are present in the bile, a fluid secreted by the liver. This group of volunteers will be aged 65 to 80 years of age.

Timeline

Start
2010-11-05
Primary completion
2011-01-27
Completion
2011-01-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Danirixin Small molecule 50 mg Oral
Subject Danirixin Small molecule 100 mg Oral
Subject Danirixin Small molecule 200 mg Oral